Transgene Biotek Limited (BOM:526139)
India
· Delayed Price · Currency is INR 2.880
+0.010 (0.35%)
At close: Apr 28, 2026
Transgene Biotek Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 2.84 | 0.08 | 0.03 | 0.15 | 0.24 | Upgrade
|
| Cash & Short-Term Investments | 0.56 | 2.84 | 0.08 | 0.03 | 0.15 | 0.24 | Upgrade
|
| Cash Growth | 399.12% | 3593.51% | 148.39% | -79.50% | -37.44% | -38.00% | Upgrade
|
| Accounts Receivable | - | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | Upgrade
|
| Receivables | - | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | Upgrade
|
| Inventory | - | 0.34 | 0.34 | 0.34 | 0.95 | 0.21 | Upgrade
|
| Other Current Assets | - | 9.37 | 10.6 | 9.99 | 5.8 | 6 | Upgrade
|
| Total Current Assets | - | 12.64 | 11.1 | 10.45 | 6.98 | 6.53 | Upgrade
|
| Property, Plant & Equipment | - | -851.25 | -867.32 | 17.57 | 18.47 | 20.29 | Upgrade
|
| Long-Term Investments | - | 0.95 | 0.95 | 0.95 | 0.95 | - | Upgrade
|
| Other Intangible Assets | - | 949.55 | 949.55 | 65.6 | 114.18 | 211.6 | Upgrade
|
| Other Long-Term Assets | - | -0 | - | -0 | 1.4 | 1.38 | Upgrade
|
| Total Assets | - | 1,441 | 1,423 | 1,424 | 1,471 | 1,569 | Upgrade
|
| Accounts Payable | - | 15.93 | 1.96 | 2.29 | 2.03 | 2.4 | Upgrade
|
| Accrued Expenses | - | 11.99 | - | - | - | - | Upgrade
|
| Short-Term Debt | - | 84.17 | 89.22 | 81.62 | 72.39 | 67.88 | Upgrade
|
| Other Current Liabilities | - | 15.28 | 20.24 | 20.76 | 17.65 | 71.51 | Upgrade
|
| Total Current Liabilities | - | 127.38 | 111.41 | 104.67 | 92.06 | 141.78 | Upgrade
|
| Long-Term Debt | - | 61.03 | 50.8 | 49.5 | 47.69 | 45.42 | Upgrade
|
| Long-Term Unearned Revenue | - | - | 1.75 | 3.51 | 5.26 | 7.02 | Upgrade
|
| Other Long-Term Liabilities | - | 1,152 | 1,152 | 1,152 | 1,152 | 1,152 | Upgrade
|
| Total Liabilities | - | 1,341 | 1,316 | 1,310 | 1,297 | 1,346 | Upgrade
|
| Common Stock | - | 757.7 | 757.7 | 757.7 | 757.7 | 757.7 | Upgrade
|
| Additional Paid-In Capital | - | 1,388 | 1,388 | 1,388 | 1,388 | 1,388 | Upgrade
|
| Retained Earnings | - | -2,306 | -2,299 | -2,293 | -2,233 | -2,008 | Upgrade
|
| Comprehensive Income & Other | - | 260.49 | 260.49 | 260.49 | 260.49 | 84.72 | Upgrade
|
| Shareholders' Equity | 92.08 | 100.3 | 107.13 | 113.69 | 173.77 | 222.39 | Upgrade
|
| Total Liabilities & Equity | - | 1,441 | 1,423 | 1,424 | 1,471 | 1,569 | Upgrade
|
| Total Debt | 165 | 145.2 | 140.01 | 131.13 | 120.08 | 113.3 | Upgrade
|
| Net Cash (Debt) | -164.44 | -142.36 | -139.93 | -131.09 | -119.93 | -113.06 | Upgrade
|
| Net Cash Per Share | -2.17 | -1.88 | -1.85 | -1.73 | -1.58 | -1.49 | Upgrade
|
| Filing Date Shares Outstanding | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | Upgrade
|
| Total Common Shares Outstanding | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | Upgrade
|
| Working Capital | - | -114.73 | -100.32 | -94.22 | -85.08 | -135.25 | Upgrade
|
| Book Value Per Share | 1.19 | 1.32 | 1.41 | 1.50 | 2.29 | 2.94 | Upgrade
|
| Tangible Book Value | 26.66 | -849.25 | -842.42 | 48.09 | 59.59 | 10.79 | Upgrade
|
| Tangible Book Value Per Share | 0.34 | -11.21 | -11.12 | 0.63 | 0.79 | 0.14 | Upgrade
|
| Land | - | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | Upgrade
|
| Buildings | - | 34.09 | 34.09 | 34.09 | 34.09 | 34.09 | Upgrade
|
| Machinery | - | 127.44 | 110.45 | 110.45 | 110.43 | 110.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.